Navigation Links
EPSScentral Responds to Pandemic Alert
Date:5/4/2009

ANNANDALE, Va., May 4 /PRNewswire/ -- EPSScentral LLC today announced its readiness to assist organizations in assembling, communicating, and implementing mitigation measures in the face of WHO's phase 5 classification of the Influenza A crisis. According to the WHO, phase 5 "...is a strong signal that a pandemic is imminent and that the time to finalize... mitigation measures is short."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080701/DC26612LOGO)

A world leader in ensuring organizational competency and performance, EPSScentral, together with pandemic content experts and technology partners, developed a package to address pandemic planning needs. Commencing with the SARS and Avian Flu crises over the past two years, EPSScentral developed the solution as a component of its process improvement and standard operating procedures practices. According to President and CEO Gary J. Dickelman, "It is socially responsible at this time to communicate our rapid, innovative approach to mitigating business disruption caused by Influenza A, especially in these challenging economic times. Having a solid plan in place mitigates overreacting to pandemic press. It prevents unnecessary business disruption while addressing the health and safety of employees in measured and responsible ways."

EPSScentral's offering includes: A baseline, easily customizable pandemic contingency plan; a set of templates and tools for rapid localization and deployment; resources to jump-start customization; and access to additional expert knowledge as the Influenza A (aka H1N1, Swine Flu) or other pandemic scenarios evolve. A sample EPSScentral pandemic plan can be viewed at http://pandemic.epssnews.com.

EPSScentral LLC is known for quality solutions that provide explicit, accessible and usable end-to-end best-practice processes; accelerate development and rollout by up to 80%; decrease time-to-competency; and foster remarkable returns on investment. Since 2002, the Company has provided thought leadership and mission critical solutions that transform business and assure the organizational mission at the speed of work. A hallmark is EPSScentral's ability to reduce organizational complexity as processes grow and supporting technologies evolve. Using EPSScentral's approach, their large private and public sector clients typically realize a ten-fold return on investment. Contact Shirah Cohen, VP, at scohen@epsscentral.net, 703-851-0545 and visit http://www.epsscentral.net.


'/>"/>
SOURCE EPSScentral LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
2. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
3. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
4. Roche responds to announcement of IDEAL hepatitis C trial results
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. USAID Cooperates in Pandemic Preparedness Initiative
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
10. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... New York , March 28, 2017 ... a largely consolidated vendor landscape, with the top three ... Agilent Technologies accounting for a significant 49% of the ... a recent report. The vendor landscape is intensely competitive ... share in the overall market. These factors have restricted ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... 2017  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a ... and other unmet medical needs, announced today two ... Research annual meeting.  The first poster to be ... of ENMD-2076 in Combination with Anti-PD1 in Syngeneic ... be presented on April 4 is entitled " ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... ... ... With less than 10,000 dermatologists in the United States and more than ... the desire to conquer breakouts and eliminate skincare stress is widespread. Curology , ... released its inaugural survey on the State of Acne in America. , The ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency ... in early March. , The seed processing plant opened in Marshallville in 2006, and ... The new office allows opportunity for transition of Patten Seed operations to the Middle ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that ... Donald Quinn. , “There were things that his parents and teachers had asked of him ... way that he was going to defy the Almighty Creator. There were some who would ...
Breaking Medicine News(10 mins):